parthenolide and Dermatitis

parthenolide has been researched along with Dermatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liebel, F; Lyte, P; Martin, K; Shapiro, S; Southall, M; Sur, R1
Asahina, A; Kagami, S; Kakinuma, T; Komine, M; Nakamura, K; Saeki, H; Sasaki, K; Tamaki, K; Tsunemi, Y1

Trials

1 trial(s) available for parthenolide and Dermatitis

ArticleYear
Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
    Inflammopharmacology, 2009, Volume: 17, Issue:1

    Topics: Adult; Animals; Anti-Inflammatory Agents; Cells, Cultured; Dermatitis; Erythema; Female; Humans; Inflammation; Inflammation Mediators; Keratinocytes; Leukocytes, Mononuclear; Macrophages; Male; Mice; Middle Aged; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Young Adult

2009

Other Studies

1 other study(ies) available for parthenolide and Dermatitis

ArticleYear
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
    Experimental dermatology, 2006, Volume: 15, Issue:2

    Topics: Cell Line; Chemokine CCL27; Chemokines; Chemokines, CC; Dermatitis; Humans; Imidazoles; Interleukin-1; Keratinocytes; Ligands; MAP Kinase Signaling System; NF-kappa B; Pyridines; Receptors, CCR10; Receptors, Chemokine; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha

2006